Delivery Order SPE2DB22D1017-SPE2DB25FF8GY

Award Date 3/21/25
Potential Completion Date 3/24/25
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $26,397.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of "WEZLANA 90 MG/ML SYRINGEML" and is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,568.57, is for the supply of "WEZLANA 90 MG/ML SYRINGEML" medical products. It is a firm fixed-price contract with a completion date of February 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,183.76 Firm Fixed Price Delivery Order contract is for the supply of "WEZLANA 90 MG/ML SYRINGEML" medical products. The contract has an ultimate completion date of April 9, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $30,555.42 for the procurement of "WEZLANA 90 MG/ML SYRINGEML" medical supplies. The contract has an ultimate completion date of March 11, 2025 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $30,705.17, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of "WEZLANA 90 MG/ML SYRINGEML" medical supplies and has a completion date of February 6, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,498.44, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 and running through November 2026. The contract is for the supply of a pharmaceutical product, "WEZLANA 90 MG/ML SYRINGEML," and does not have a...
This federal contract award, valued at $28,226.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of "WEZLANA 90 MG/ML SYRINGEML", a medical product, with a performance period through February 2025. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,150.95 firm fixed-price contract is for the supply of WEZLANA 90 MG/ML syringes. The contract has a period of performance through March 27, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
This is a $7,303.43 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEZLANA 90 MG/ML SYRINGEML, a pharmaceutical product, with a period of performance through March 13, 2025. This contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,327.37 firm fixed-price delivery order is for WEZLANA 90 MG/ML SYRINGEML medical supplies, with a period of performance through March 26, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF8GY
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $27,914.02, is for the delivery of a specific pharmaceutical product, "WEZLANA 90 MG/ML SYRINGEML," to support military healthcare programs. The contract has an ultimate completion date of March 24, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award was not designated with any set-aside requirements, indicating open competition.

Generated 6/21/25, 9:50 AM